1 Rheumatoid Arthritis Devices Market Overview 1.1 Product Overview and Scope of Rheumatoid Arthritis Devices 1.2 Rheumatoid Arthritis Devices Segment by Type 1.2.1 Global Rheumatoid Arthritis Devices Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Implantable Joint Prostheses 1.2.3 Spinal Devices 1.2.4 Other 1.3 Rheumatoid Arthritis Devices Segment by Application 1.3.1 Global Rheumatoid Arthritis Devices Sales Comparison by Application: (2021-2027) 1.3.2 Elderly 1.3.3 Young adults 1.4 Global Rheumatoid Arthritis Devices Market Size Estimates and Forecasts 1.4.1 Global Rheumatoid Arthritis Devices Revenue 2016-2027 1.4.2 Global Rheumatoid Arthritis Devices Sales 2016-2027 1.4.3 Rheumatoid Arthritis Devices Market Size by Region: 2016 Versus 2021 Versus 2027 2 Rheumatoid Arthritis Devices Market Competition by Manufacturers 2.1 Global Rheumatoid Arthritis Devices Sales Market Share by Manufacturers (2016-2021) 2.2 Global Rheumatoid Arthritis Devices Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Rheumatoid Arthritis Devices Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Rheumatoid Arthritis Devices Manufacturing Sites, Area Served, Product Type 2.5 Rheumatoid Arthritis Devices Market Competitive Situation and Trends 2.5.1 Rheumatoid Arthritis Devices Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Rheumatoid Arthritis Devices Players Market Share by Revenue 2.5.3 Global Rheumatoid Arthritis Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Rheumatoid Arthritis Devices Retrospective Market Scenario by Region 3.1 Global Rheumatoid Arthritis Devices Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Rheumatoid Arthritis Devices Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Rheumatoid Arthritis Devices Market Facts & Figures by Country 3.3.1 North America Rheumatoid Arthritis Devices Sales by Country 3.3.2 North America Rheumatoid Arthritis Devices Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe Rheumatoid Arthritis Devices Market Facts & Figures by Country 3.4.1 Europe Rheumatoid Arthritis Devices Sales by Country 3.4.2 Europe Rheumatoid Arthritis Devices Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Rheumatoid Arthritis Devices Market Facts & Figures by Region 3.5.1 Asia Pacific Rheumatoid Arthritis Devices Sales by Region 3.5.2 Asia Pacific Rheumatoid Arthritis Devices Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Rheumatoid Arthritis Devices Market Facts & Figures by Country 3.6.1 Latin America Rheumatoid Arthritis Devices Sales by Country 3.6.2 Latin America Rheumatoid Arthritis Devices Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Rheumatoid Arthritis Devices Market Facts & Figures by Country 3.7.1 Middle East and Africa Rheumatoid Arthritis Devices Sales by Country 3.7.2 Middle East and Africa Rheumatoid Arthritis Devices Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Rheumatoid Arthritis Devices Historic Market Analysis by Type 4.1 Global Rheumatoid Arthritis Devices Sales Market Share by Type (2016-2021) 4.2 Global Rheumatoid Arthritis Devices Revenue Market Share by Type (2016-2021) 4.3 Global Rheumatoid Arthritis Devices Price by Type (2016-2021) 5 Global Rheumatoid Arthritis Devices Historic Market Analysis by Application 5.1 Global Rheumatoid Arthritis Devices Sales Market Share by Application (2016-2021) 5.2 Global Rheumatoid Arthritis Devices Revenue Market Share by Application (2016-2021) 5.3 Global Rheumatoid Arthritis Devices Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Active Implants LLC 6.1.1 Active Implants LLC Corporation Information 6.1.2 Active Implants LLC Description and Business Overview 6.1.3 Active Implants LLC Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Active Implants LLC Rheumatoid Arthritis Devices Product Portfolio 6.1.5 Active Implants LLC Recent Developments/Updates 6.2 Anika Therapeutics, Inc. 6.2.1 Anika Therapeutics, Inc. Corporation Information 6.2.2 Anika Therapeutics, Inc. Description and Business Overview 6.2.3 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Product Portfolio 6.2.5 Anika Therapeutics, Inc. Recent Developments/Updates 6.3 Arthrex, Inc. 6.3.1 Arthrex, Inc. Corporation Information 6.3.2 Arthrex, Inc. Description and Business Overview 6.3.3 Arthrex, Inc. Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Arthrex, Inc. Rheumatoid Arthritis Devices Product Portfolio 6.3.5 Arthrex, Inc. Recent Developments/Updates 6.4 Asahi Kasei Pharma Corporation 6.4.1 Asahi Kasei Pharma Corporation Corporation Information 6.4.2 Asahi Kasei Pharma Corporation Description and Business Overview 6.4.3 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Product Portfolio 6.4.5 Asahi Kasei Pharma Corporation Recent Developments/Updates 6.5 B. Braun Melsungen AG 6.5.1 B. Braun Melsungen AG Corporation Information 6.5.2 B. Braun Melsungen AG Description and Business Overview 6.5.3 B. Braun Melsungen AG Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2016-2021) 6.5.4 B. Braun Melsungen AG Rheumatoid Arthritis Devices Product Portfolio 6.5.5 B. Braun Melsungen AG Recent Developments/Updates 6.6 CONMED Corporation 6.6.1 CONMED Corporation Corporation Information 6.6.2 CONMED Corporation Description and Business Overview 6.6.3 CONMED Corporation Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2016-2021) 6.6.4 CONMED Corporation Rheumatoid Arthritis Devices Product Portfolio 6.6.5 CONMED Corporation Recent Developments/Updates 6.7 EMulate Therapeutics, Inc. (Nativis, Inc.) 6.6.1 EMulate Therapeutics, Inc. (Nativis, Inc.) Corporation Information 6.6.2 EMulate Therapeutics, Inc. (Nativis, Inc.) Description and Business Overview 6.6.3 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2016-2021) 6.4.4 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Product Portfolio 6.7.5 EMulate Therapeutics, Inc. (Nativis, Inc.) Recent Developments/Updates 6.8 Integra Lifesciences Corporation 6.8.1 Integra Lifesciences Corporation Corporation Information 6.8.2 Integra Lifesciences Corporation Description and Business Overview 6.8.3 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Product Portfolio 6.8.5 Integra Lifesciences Corporation Recent Developments/Updates 6.9 Johnson & Johnson (DePuy Synthes Inc.) 6.9.1 Johnson & Johnson (DePuy Synthes Inc.) Corporation Information 6.9.2 Johnson & Johnson (DePuy Synthes Inc.) Description and Business Overview 6.9.3 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Product Portfolio 6.9.5 Johnson & Johnson (DePuy Synthes Inc.) Recent Developments/Updates 6.10 Novartis AG 6.10.1 Novartis AG Corporation Information 6.10.2 Novartis AG Description and Business Overview 6.10.3 Novartis AG Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Novartis AG Rheumatoid Arthritis Devices Product Portfolio 6.10.5 Novartis AG Recent Developments/Updates 6.11 RTI Surgical, Inc. 6.11.1 RTI Surgical, Inc. Corporation Information 6.11.2 RTI Surgical, Inc. Rheumatoid Arthritis Devices Description and Business Overview 6.11.3 RTI Surgical, Inc. Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2016-2021) 6.11.4 RTI Surgical, Inc. Rheumatoid Arthritis Devices Product Portfolio 6.11.5 RTI Surgical, Inc. Recent Developments/Updates 6.12 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) 6.12.1 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Corporation Information 6.12.2 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Description and Business Overview 6.12.3 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2016-2021) 6.12.4 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Product Portfolio 6.12.5 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Recent Developments/Updates 6.13 Setpoint Medical Corporation 6.13.1 Setpoint Medical Corporation Corporation Information 6.13.2 Setpoint Medical Corporation Rheumatoid Arthritis Devices Description and Business Overview 6.13.3 Setpoint Medical Corporation Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2016-2021) 6.13.4 Setpoint Medical Corporation Rheumatoid Arthritis Devices Product Portfolio 6.13.5 Setpoint Medical Corporation Recent Developments/Updates 6.14 Smith & Nephew plc (Osiris Therapeutics, Inc.) 6.14.1 Smith & Nephew plc (Osiris Therapeutics, Inc.) Corporation Information 6.14.2 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Description and Business Overview 6.14.3 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2016-2021) 6.14.4 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Product Portfolio 6.14.5 Smith & Nephew plc (Osiris Therapeutics, Inc.) Recent Developments/Updates 6.15 Stryker Corporation (OrthoSpace Ltd.) 6.15.1 Stryker Corporation (OrthoSpace Ltd.) Corporation Information 6.15.2 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Description and Business Overview 6.15.3 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2016-2021) 6.15.4 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Product Portfolio 6.15.5 Stryker Corporation (OrthoSpace Ltd.) Recent Developments/Updates 6.16 UCB Pharma S.A. 6.16.1 UCB Pharma S.A. Corporation Information 6.16.2 UCB Pharma S.A. Rheumatoid Arthritis Devices Description and Business Overview 6.16.3 UCB Pharma S.A. Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2016-2021) 6.16.4 UCB Pharma S.A. Rheumatoid Arthritis Devices Product Portfolio 6.16.5 UCB Pharma S.A. Recent Developments/Updates 6.17 Zimmer Biomet 6.17.1 Zimmer Biomet Corporation Information 6.17.2 Zimmer Biomet Rheumatoid Arthritis Devices Description and Business Overview 6.17.3 Zimmer Biomet Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2016-2021) 6.17.4 Zimmer Biomet Rheumatoid Arthritis Devices Product Portfolio 6.17.5 Zimmer Biomet Recent Developments/Updates 7 Rheumatoid Arthritis Devices Manufacturing Cost Analysis 7.1 Rheumatoid Arthritis Devices Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Rheumatoid Arthritis Devices 7.4 Rheumatoid Arthritis Devices Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Rheumatoid Arthritis Devices Distributors List 8.3 Rheumatoid Arthritis Devices Customers 9 Rheumatoid Arthritis Devices Market Dynamics 9.1 Rheumatoid Arthritis Devices Industry Trends 9.2 Rheumatoid Arthritis Devices Growth Drivers 9.3 Rheumatoid Arthritis Devices Market Challenges 9.4 Rheumatoid Arthritis Devices Market Restraints 10 Global Market Forecast 10.1 Rheumatoid Arthritis Devices Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Rheumatoid Arthritis Devices by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Rheumatoid Arthritis Devices by Type (2022-2027) 10.2 Rheumatoid Arthritis Devices Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Rheumatoid Arthritis Devices by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Rheumatoid Arthritis Devices by Application (2022-2027) 10.3 Rheumatoid Arthritis Devices Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Rheumatoid Arthritis Devices by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Rheumatoid Arthritis Devices by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Rheumatoid Arthritis Devices Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Rheumatoid Arthritis Devices Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Rheumatoid Arthritis Devices Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Rheumatoid Arthritis Devices Covered in This Study Table 5. Global Rheumatoid Arthritis Devices Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Rheumatoid Arthritis Devices Sales Market Share by Manufacturers (2016-2021) Table 7. Global Rheumatoid Arthritis Devices Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Rheumatoid Arthritis Devices Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Rheumatoid Arthritis Devices Average Price (US$/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Rheumatoid Arthritis Devices Manufacturing Sites and Area Served Table 11. Manufacturers Rheumatoid Arthritis Devices Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Rheumatoid Arthritis Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatoid Arthritis Devices as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Rheumatoid Arthritis Devices Sales by Region (2016-2021) & (K Units) Table 16. Global Rheumatoid Arthritis Devices Sales Market Share by Region (2016-2021) Table 17. Global Rheumatoid Arthritis Devices Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Rheumatoid Arthritis Devices Sales by Country (2016-2021) & (K Units) Table 19. North America Rheumatoid Arthritis Devices Sales Market Share by Country (2016-2021) Table 20. North America Rheumatoid Arthritis Devices Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Rheumatoid Arthritis Devices Revenue Market Share by Country (2016-2021) Table 22. Europe Rheumatoid Arthritis Devices Sales by Country (2016-2021) & (K Units) Table 23. Europe Rheumatoid Arthritis Devices Sales Market Share by Country (2016-2021) Table 24. Europe Rheumatoid Arthritis Devices Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Rheumatoid Arthritis Devices Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Rheumatoid Arthritis Devices Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Rheumatoid Arthritis Devices Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Rheumatoid Arthritis Devices Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Rheumatoid Arthritis Devices Revenue Market Share by Region (2016-2021) Table 30. Latin America Rheumatoid Arthritis Devices Sales by Country (2016-2021) & (K Units) Table 31. Latin America Rheumatoid Arthritis Devices Sales Market Share by Country (2016-2021) Table 32. Latin America Rheumatoid Arthritis Devices Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Rheumatoid Arthritis Devices Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Rheumatoid Arthritis Devices Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Rheumatoid Arthritis Devices Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Rheumatoid Arthritis Devices Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Rheumatoid Arthritis Devices Revenue Market Share by Country (2016-2021) Table 38. Global Rheumatoid Arthritis Devices Sales (K Units) by Type (2016-2021) Table 39. Global Rheumatoid Arthritis Devices Sales Market Share by Type (2016-2021) Table 40. Global Rheumatoid Arthritis Devices Revenue (Million US$) by Type (2016-2021) Table 41. Global Rheumatoid Arthritis Devices Revenue Share by Type (2016-2021) Table 42. Global Rheumatoid Arthritis Devices Price (US$/Unit) by Type (2016-2021) Table 43. Global Rheumatoid Arthritis Devices Sales (K Units) by Application (2016-2021) Table 44. Global Rheumatoid Arthritis Devices Sales Market Share by Application (2016-2021) Table 45. Global Rheumatoid Arthritis Devices Revenue (Million US$) by Application (2016-2021) Table 46. Global Rheumatoid Arthritis Devices Revenue Share by Application (2016-2021) Table 47. Global Rheumatoid Arthritis Devices Price (US$/Unit) by Application (2016-2021) Table 48. Active Implants LLC Corporation Information Table 49. Active Implants LLC Description and Business Overview Table 50. Active Implants LLC Rheumatoid Arthritis Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 51. Active Implants LLC Rheumatoid Arthritis Devices Product Table 52. Active Implants LLC Recent Developments/Updates Table 53. Anika Therapeutics, Inc. Corporation Information Table 54. Anika Therapeutics, Inc. Description and Business Overview Table 55. Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 56. Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Product Table 57. Anika Therapeutics, Inc. Recent Developments/Updates Table 58. Arthrex, Inc. Corporation Information Table 59. Arthrex, Inc. Description and Business Overview Table 60. Arthrex, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 61. Arthrex, Inc. Rheumatoid Arthritis Devices Product Table 62. Arthrex, Inc. Recent Developments/Updates Table 63. Asahi Kasei Pharma Corporation Corporation Information Table 64. Asahi Kasei Pharma Corporation Description and Business Overview Table 65. Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 66. Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Product Table 67. Asahi Kasei Pharma Corporation Recent Developments/Updates Table 68. B. Braun Melsungen AG Corporation Information Table 69. B. Braun Melsungen AG Description and Business Overview Table 70. B. Braun Melsungen AG Rheumatoid Arthritis Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 71. B. Braun Melsungen AG Rheumatoid Arthritis Devices Product Table 72. B. Braun Melsungen AG Recent Developments/Updates Table 73. CONMED Corporation Corporation Information Table 74. CONMED Corporation Description and Business Overview Table 75. CONMED Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 76. CONMED Corporation Rheumatoid Arthritis Devices Product Table 77. CONMED Corporation Recent Developments/Updates Table 78. EMulate Therapeutics, Inc. (Nativis, Inc.) Corporation Information Table 79. EMulate Therapeutics, Inc. (Nativis, Inc.) Description and Business Overview Table 80. EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 81. EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Product Table 82. EMulate Therapeutics, Inc. (Nativis, Inc.) Recent Developments/Updates Table 83. Integra Lifesciences Corporation Corporation Information Table 84. Integra Lifesciences Corporation Description and Business Overview Table 85. Integra Lifesciences Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 86. Integra Lifesciences Corporation Rheumatoid Arthritis Devices Product Table 87. Integra Lifesciences Corporation Recent Developments/Updates Table 88. Johnson & Johnson (DePuy Synthes Inc.) Corporation Information Table 89. Johnson & Johnson (DePuy Synthes Inc.) Description and Business Overview Table 90. Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 91. Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Product Table 92. Johnson & Johnson (DePuy Synthes Inc.) Recent Developments/Updates Table 93. Novartis AG Corporation Information Table 94. Novartis AG Description and Business Overview Table 95. Novartis AG Rheumatoid Arthritis Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 96. Novartis AG Rheumatoid Arthritis Devices Product Table 97. Novartis AG Recent Developments/Updates Table 98. RTI Surgical, Inc. Corporation Information Table 99. RTI Surgical, Inc. Description and Business Overview Table 100. RTI Surgical, Inc. Rheumatoid Arthritis Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 101. RTI Surgical, Inc. Rheumatoid Arthritis Devices Product Table 102. RTI Surgical, Inc. Recent Developments/Updates Table 103. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Corporation Information Table 104. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Description and Business Overview Table 105. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 106. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Product Table 107. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Recent Developments/Updates Table 108. Setpoint Medical Corporation Corporation Information Table 109. Setpoint Medical Corporation Description and Business Overview Table 110. Setpoint Medical Corporation Rheumatoid Arthritis Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 111. Setpoint Medical Corporation Rheumatoid Arthritis Devices Product Table 112. Setpoint Medical Corporation Recent Developments/Updates Table 113. Smith & Nephew plc (Osiris Therapeutics, Inc.) Corporation Information Table 114. Smith & Nephew plc (Osiris Therapeutics, Inc.) Description and Business Overview Table 115. Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 116. Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Product Table 117. Smith & Nephew plc (Osiris Therapeutics, Inc.) Recent Developments/Updates Table 118. Stryker Corporation (OrthoSpace Ltd.) Corporation Information Table 119. Stryker Corporation (OrthoSpace Ltd.) Description and Business Overview Table 120. Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 121. Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Product Table 122. Stryker Corporation (OrthoSpace Ltd.) Recent Developments/Updates Table 123. UCB Pharma S.A. Corporation Information Table 124. UCB Pharma S.A. Description and Business Overview Table 125. UCB Pharma S.A. Rheumatoid Arthritis Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 126. UCB Pharma S.A. Rheumatoid Arthritis Devices Product Table 127. UCB Pharma S.A. Recent Developments/Updates Table 128. Zimmer Biomet Corporation Information Table 129. Zimmer Biomet Description and Business Overview Table 130. Zimmer Biomet Rheumatoid Arthritis Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 131. Zimmer Biomet Rheumatoid Arthritis Devices Product Table 132. Zimmer Biomet Recent Developments/Updates Table 133. Production Base and Market Concentration Rate of Raw Material Table 134. Key Suppliers of Raw Materials Table 135. Rheumatoid Arthritis Devices Distributors List Table 136. Rheumatoid Arthritis Devices Customers List Table 137. Rheumatoid Arthritis Devices Market Trends Table 138. Rheumatoid Arthritis Devices Growth Drivers Table 139. Rheumatoid Arthritis Devices Market Challenges Table 140. Rheumatoid Arthritis Devices Market Restraints Table 141. Global Rheumatoid Arthritis Devices Sales Forecast by Type (2022-2027) & (K Units) Table 142. Global Rheumatoid Arthritis Devices Sales Market Share Forecast by Type (2022-2027) Table 143. Global Rheumatoid Arthritis Devices Revenue Forecast by Type (2022-2027) & (US$ Million) Table 144. Global Rheumatoid Arthritis Devices Revenue Market Share Forecast by Type (2022-2027) Table 145. Global Rheumatoid Arthritis Devices Sales Forecast by Application (2022-2027) & (K Units) Table 146. Global Rheumatoid Arthritis Devices Sales Market Share Forecast by Application (2022-2027) Table 147. Global Rheumatoid Arthritis Devices Revenue Forecast by Application (2022-2027) & (US$ Million) Table 148. Global Rheumatoid Arthritis Devices Revenue Market Share Forecast by Application (2022-2027) Table 149. Global Rheumatoid Arthritis Devices Sales Forecast by Region (2022-2027) & (K Units) Table 150. Global Rheumatoid Arthritis Devices Sales Market Share Forecast by Region (2022-2027) Table 151. Global Rheumatoid Arthritis Devices Revenue Forecast by Region (2022-2027) & (US$ Million) Table 152. Global Rheumatoid Arthritis Devices Revenue Market Share Forecast by Region (2022-2027) Table 153. Research Programs/Design for This Report Table 154. Key Data Information from Secondary Sources Table 155. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Rheumatoid Arthritis Devices Figure 2. Global Rheumatoid Arthritis Devices Market Share by Type in 2020 & 2027 Figure 3. Implantable Joint Prostheses Product Picture Figure 4. Spinal Devices Product Picture Figure 5. Other Product Picture Figure 6. Global Rheumatoid Arthritis Devices Market Share by Application in 2020 & 2027 Figure 7. Elderly Figure 8. Young adults Figure 9. Global Rheumatoid Arthritis Devices Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Rheumatoid Arthritis Devices Market Size 2016-2027 (US$ Million) Figure 11. Global Rheumatoid Arthritis Devices Sales 2016-2027 (K Units) Figure 12. Global Rheumatoid Arthritis Devices Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Rheumatoid Arthritis Devices Sales Share by Manufacturers in 2020 Figure 14. Global Rheumatoid Arthritis Devices Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Rheumatoid Arthritis Devices Players: Market Share by Revenue in 2020 Figure 16. Rheumatoid Arthritis Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Rheumatoid Arthritis Devices Sales Market Share by Region (2016-2021) Figure 18. Global Rheumatoid Arthritis Devices Sales Market Share by Region in 2020 Figure 19. Global Rheumatoid Arthritis Devices Revenue Market Share by Region (2016-2021) Figure 20. Global Rheumatoid Arthritis Devices Revenue Market Share by Region in 2020 Figure 21. United States Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Mexico Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Brazil Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Argentina Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Turkey Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Saudi Arabia Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. UAE Rheumatoid Arthritis Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Sales Market Share of Rheumatoid Arthritis Devices by Type (2016-2021) Figure 44. Sales Market Share of Rheumatoid Arthritis Devices by Application (2016-2021) Figure 45. Sales Market Share of Rheumatoid Arthritis Devices by Application in 2020 Figure 46. Revenue Share of Rheumatoid Arthritis Devices by Application (2016-2021) Figure 47. Revenue Share of Rheumatoid Arthritis Devices by Application in 2020 Figure 48. Manufacturing Cost Structure of Rheumatoid Arthritis Devices Figure 49. Manufacturing Process Analysis of Rheumatoid Arthritis Devices Figure 50. Rheumatoid Arthritis Devices Industrial Chain Analysis Figure 51. Channels of Distribution Figure 52. Distributors Profiles Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

Active Implants LLC Anika Therapeutics, Inc. Arthrex, Inc. Asahi Kasei Pharma Corporation B. Braun Melsungen AG CONMED Corporation EMulate Therapeutics, Inc. (Nativis, Inc.) Integra Lifesciences Corporation Johnson & Johnson (DePuy Synthes Inc.) Novartis AG RTI Surgical, Inc. Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Setpoint Medical Corporation Smith & Nephew plc (Osiris Therapeutics, Inc.) Stryker Corporation (OrthoSpace Ltd.) UCB Pharma S.A. Zimmer Biomet